Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients [NA]
Clinical trial on ACE inhibitors in patients undergoing total hip and knee arthroplasty has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of multiple doses of valsartan in children with hypertension with or without chro…
-
FDA approval · 2017-09-22FDA Approved: INDAPAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Indapamide (ANI Pharmaceuticals), updating its regulatory approval.
-
FDA approval · 2017-09-19FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (BluePoint Laboratories Inc.)
FDA approved an original application for labetalol hydrochloride from BluePoint Laboratories Inc., granting a generic version of the drug ma…
-
FDA approval · 2017-09-19FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved Unichem Pharmaceuticals' original ANDA for a generic fixed-dose combination tablet of irbesartan and hydrochlorothiazide. I…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Reducing Total Cardiovascular Risk in an Urban Community [Phase 4]
Phase 4 clinical trial update aimed at reducing overall cardiovascular risk in an urban community; completed with results posted in 2017.
-
FDA label_change · 2017-09-14FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC, typically involving a label change or n…
-
FDA label_change · 2017-09-14FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) from Waylis Therapeutics LLC, detailing changes related to the C…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension [Phase 4]
Phase 4 clinical trial assessing molecular genetics of drug responsiveness in essential hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension [Phase 4]
A Phase 4 randomized trial evaluating sertraline for hypertension is reported, with ongoing status and sponsor information provided.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function [Phase 4]
A Phase 4 study evaluating the effects of renin inhibition on fibrinolytic balance and endothelial function in hypertension has completed. R…
-
FDA approval · 2017-08-23FDA Approved: CANDESARTAN CILEXETIL — Original Application (Zydus Lifesciences Limited)
FDA approved the Original Application for candesartan cilexetil by Zydus Lifesciences Limited, confirming a generic version of the antihyper…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics [Phase 4]
This document reports a Phase 4 clinical trial update examining potential adverse drug reactions between renin-angiotensin system blockers a…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled [Phase 4]
This clinical trial update describes a Phase 4 study evaluating the efficacy of a telmisartan/amlodipine combination for 24-hour blood press…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
This clinical trial update reports on the blood pressure-lowering effects of Amosartan in patients with hypertension. The study status is co…
-
CLINICAL_TRIALS research · 2017-08-21Clinical Trial Update: Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population
This clinical trial update describes a study in the Chinese population using non-invasive aortic ambulatory blood pressure monitoring to det…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Metformin Versus Vildagliptin for Diabetic Hypertensive Patients [Phase 4]
Phase 4 trial comparing metformin and vildagliptin in patients with type 2 diabetes and hypertension, completed to evaluate effects on blood…
-
CLINICAL_TRIALS withdrawal · 2017-08-18Clinical Trial Update: EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network [Phase 4]
A Phase 4 trial comparing initial diuretic therapies for hypertension, sponsored by Johns Hopkins University, has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Lowering Blood Pressure in Primary Care in Vienna [Phase 4]
Phase 4 clinical trial in Vienna evaluating strategies to lower blood pressure in primary care has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: DUCS-DHD Determinants of Hypertension in Tanzania
The ClinicalTrials.gov entry DUCS-DHD Determinants of Hypertension in Tanzania reports a completed trial studying factors that determine hyp…
-
CLINICAL_TRIALS research · 2017-08-15Clinical Trial Update: Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) [Phase 3]
Phase 3 clinical trial update for the Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) program addressing hypertension; curre…
-
FDA approval · 2017-08-14FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a fixed-dose combination of amlodipine and olmesartan medoxomil for treating …
-
FDA approval · 2017-08-11FDA Approved: TIADYLT ER — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approves TIADYLT ER (diltiazem hydrochloride extended-release) from Zydus Pharmaceuticals (USA) Inc. under an original ANDA, providing a…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Safety for 24 Weeks Intake of Korean Red Ginseng in Adults [NA]
This update reports safety findings from a 24-week intake of Korean Red Ginseng in adults, including healthy individuals and those with diab…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of a fixed-dose combination of fimasartan, amlodipine, and rosuvastatin (NCT0299572…